Comparing Efficacy and Safety of CinnaGen Biosimilar Growth Hormone (CinnaTropin®) Versus Nordilet in Children With Idiopathic Growth Hormone Deficiency

NCT03223025 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Growth Hormone Deficiency

Interventions

DRUG: CinnaTropin®
DRUG: Nordilet®

Sponsor

Cinnagen